In The Press February 03, 2021

The Science Of Success: UK Biotech Financing In 2020 — Mergers and Acquisitions (UK BioIndustry Association)

Amidst the turbulent year, some important M&A deals were executed, including high-value exits that returned capital to investors. Head of European Strategic Relationships at Goodwin, Markus Bauman, describes how clients have taken advantage of a robust market for traditional deal structures like IPOs and M&A, but also seeing another financial product, SPACs, become a key part of the tool-kit for the most ambitious UK biotechs. Read the UK BioIndustry Association article here.